Trials / Completed
CompletedNCT00810238
C-Cure Clinical Trial
C-Cure - Safety, Feasibility and Efficacy of Guided Bone Marrow-derived Mesenchymal Cardiopoietic Cells for the Treatment of Heart Failure Secondary to Ischemic Cardiomyopathy
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 240 (estimated)
- Sponsor
- Celyad Oncology SA · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical trial is to evaluate the feasibility, safety and efficacy of left ventricular endocardial injection of guided bone marrow-derived cardiopoietic cells (C-Cure) in the setting of chronic heart failure secondary to ischemic cardiomyopathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | C-Cure | Intraventricular injection |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2010-07-01
- Completion
- 2012-01-01
- First posted
- 2008-12-18
- Last updated
- 2012-09-05
Locations
8 sites across 2 countries: Belgium, Serbia
Source: ClinicalTrials.gov record NCT00810238. Inclusion in this directory is not an endorsement.